Philadelphia Business Journal
By John George
The Philadelphia region again ranks among the top 10 in a trade publication’s assessment of the country’s top markets for biopharma activity.
Genetic Engineering & Biotechnology News (GEN) ranked Philadelphia seventh on its top 10 list of biopharma clusters, down one spot from its sixth-place finish in 2019 when GEN last published its analysis.
The report measures U.S. cities and regions based on four quantifiable factors: funding for life sciences, patents awarded, lab space and number of life sciences jobs.
